ES71
TEAS SECTION 71 RECEIVED
29/06/2026
Voltar para busca
Dado oficial do USPTO
ALK
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
69
Atualização mais recente
29/06/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
1, 5, 44
Data de depósito
20/11/2013
Data de registro
28/06/2016
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
15/12/2022
Última transação
29/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
708
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
99
Localização do titular
Hørsholm, DK
Examinador
STRUCK, ROBERT J
Unidade examinadora
L90
Descrição da marca
The mark consists of the stylized wording "ALK" with a design of dots forming part of the "A".
Titulares e representantes
Titulares
ALK-Abelló A/S
Representantes
B. Brett Heavner Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in research and science; diagnostic preparations for scientific or research purposesdiagnostic preparations for the treatmentmonitoring and diagnosing of diseases such as allergiesasthmarhinitis and respiratory diseases
Classe 5
Pharmaceutical and veterinary preparationspharmaceutical and veterinary preparations for immunotherapeutic purposes and pharmaceutical and veterinary preparations for diagnosisprevention and treatment of allergyasthmaallergic rhinitisallergic asthma and respiratory allergic diseases; diagnostic preparations for medical purposesdiagnostic reagents for medical use; diagnostic testing kits comprised of diagnostic assaysspecimen holdersdiagnostic preparation agents and specimen preparation agents for medical use ; pharmaceutical preparations in the form of injectable pharmaceuticalsparticularly adrenalinefor treatment of anaphylactic reactions
Classe 44
Medical services and medical healthcare services; medical consulting servicescounselling and information regarding immunotherapyallergyasthmaallergic rhinitisallergic asthmarespiratory allergic diseases and anaphylactic reactions; providing patient support relating to immunotherapy as well as to diagnosingprevention and treatment of allergyasthmaallergic rhinitisallergic asthmarespiratory allergic diseases and anaphylactic reactionsmedical consultations; providing medical information to medical professionals relating to immunotherapy as well as to diagnosingprevention and treatment of allergyasthmaallergic rhinitisallergic asthmarespiratory allergic diseases and anaphylactic reactions; providing a website featuring medical information to medical professionals relating to immunotherapy as well as to diagnosingprevention and treatment of allergyasthmaallergic rhinitisallergic asthmarespiratory allergic diseases and anaphylactic reactions; medical testing for diagnostic or treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
69 publicações encontradas
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
28/06/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/10/2024
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
23/10/2023
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
08/09/2023
INPC
INVALIDATION PROCESSED
07/09/2023
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
15/08/2023
RNWL
INTERNATIONAL REGISTRATION RENEWED
15/06/2023
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
15/12/2022
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
15/12/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/12/2022
ES75
TEAS SECTION 71 & 15 RECEIVED
28/06/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
28/06/2021
NREP
NEW REPRESENTATIVE AT IB RECEIVED
23/01/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
20/05/2017
XXSS
GENERIC MADRID TRANSACTION SENT TO IB
20/10/2016
XXCR
GENERIC MADRID TRANSACTION CREATED
20/10/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
28/09/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
15/09/2016
IROP
IRREGULARITY ON NOTICE OF POSSIBLE OPPOSITION RECEIVED FROM IB
25/07/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
28/06/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/04/2016
PUBO
PUBLISHED FOR OPPOSITION
12/04/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
23/03/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
23/03/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
23/03/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/03/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/03/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
26/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
25/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
25/02/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/10/2015
GNRT
NON-FINAL ACTION E-MAILED
01/10/2015
CNRT
NON-FINAL ACTION WRITTEN
01/10/2015
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/09/2015
ALIE
ASSIGNED TO LIE
03/09/2015
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
05/02/2015
CORN
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
05/02/2015
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
30/01/2015
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
30/01/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
27/01/2015
GNSL
LETTER OF SUSPENSION E-MAILED
27/01/2015
CNSL
SUSPENSION LETTER WRITTEN
27/01/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/01/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/01/2015
ALIE
ASSIGNED TO LIE
05/01/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/12/2014
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/12/2014
GNFR
FINAL REFUSAL E-MAILED
04/12/2014
CNFR
FINAL REFUSAL WRITTEN
04/12/2014
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
26/11/2014
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
18/11/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/11/2014
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
14/11/2014
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
14/11/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
13/11/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/11/2014
LIME
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
04/11/2014
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
23/10/2014
RFNT
REFUSAL PROCESSED BY IB
30/05/2014
MAFR
APPLICATION FILING RECEIPT MAILED
16/05/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
14/05/2014
RFRR
REFUSAL PROCESSED BY MPU
14/05/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
14/05/2014
CNRT
NON-FINAL ACTION WRITTEN
13/05/2014
DOCK
ASSIGNED TO EXAMINER
12/05/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/05/2014
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
08/05/2014
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/05/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALK ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.